ArticleJSES international2025
Description of a new surgical approach for elbow arthroplasty: Selective Triceps-On Medial Paraolecranon (STOMP) approach.
Article in JSES international, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Medial single-window approach to the elbow: a triceps-on technique that does not violate the olecranon bursa.JSES reviews, reports, and techniques · 2026Article
- Current outcomes of triceps-sparing elbow arthroplasties: a systematic review.JSES reviews, reports, and techniques · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Surgical approaches for total elbow arthroplasty (TEA) are broadly divided into two groups; "triceps-off" and "triceps-on" approaches. Traditional "triceps-off" approaches provide excellent visualization for TEA; however, they carry a risk of triceps failure and require triceps protecting rehabilitation protocols. Triceps-on approaches have the advantage of preservation of triceps function yet present technical challenges for access to and preparation of the bony surfaces of the proximal ulna and radius. We present here the operative technique, indications, and initial outcomes of a novel Selective Triceps-On Medial Paraolecranon (STOMP) approach for TEA, which allows both preservation of the triceps function and excellent exposure to the proximal ulna with minimal risk to the ulnar nerve. Methods: A two center, retrospective cohort study of all patients undergoing primary TEA, hemiarthroplasty, or revision elbow arthroplasties using the STOMP approach in the practice of the senior authors between 2010 and 2020 were reviewed. Patient data, including admission demographics and diagnoses were collated. Outcome measures were collected from patient charts. Results: A total of 37 elbow arthroplasties in 35 patients were performed with the STOMP approach during the reviewed period, of which 27 patients (77%) were female. Thirty-two arthroplasties were primary cases (86%), and 5 (14%) were revision cases. The main indications leading to elbow arthroplasty was rheumatoid arthritis (n = 18, 49%) followed by primary or secondary elbow osteoarthritis (n = 9, 24%) and distal humeral fracture (n = 7, 19%). There were 7 postoperative complications (19%). Five patients (14%) developed elbow stiffness, one patient a postoperative olecranon fracture (n = 1, 3%) and one patient had an ulnar nerve injury with incomplete resolution but that did not warrant surgical treatment (n = 1, 3%). A reoperation was required in 3 patients (9%). Conclusion: The STOMP approach is a safe approach for elbow arthroplasty surgery. It does not detach the triceps and we believe it offers improved exposure and safety compared to other triceps-on techniques. Furthermore, this approach allows excellent surgical access to the coronoid, olecranon, and ulnar canal with low midterm complications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.